Okabena Investment Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,119
Closed -$1.36M 129
2025
Q1
$1.36M Buy
+3,119
New +$1.25M 0.34% 56
2024
Q3
Sell
-977
Closed -$529K 111
2024
Q2
$529K Sell
977
-314
-24% -$166K 0.17% 84
2024
Q1
$669K Sell
1,291
-145
-10% -$72.1K 0.22% 78
2023
Q4
$677K Sell
1,436
-78
-5% -$36.1K 0.26% 74
2023
Q3
$659K Sell
1,514
-103
-6% -$46.7K 0.51% 46
2023
Q2
$718K Buy
+1,617
New +$746K 0.53% 50
2020
Q1
Sell
-2,973
Closed -$898K 73
2019
Q4
$898K Buy
+2,973
New +$818K 0.83% 46

Other funds holding ELV

Okabena Investment Services's ELV Position: Q2 2025 in Review

Okabena Investment Services sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 3,119 shares — an estimated $1.36M sold.

Okabena Investment Services first reported a position in ELV in Q4 2019 and held it in 7 quarters. The position peaked at $1.36M in Q1 2025. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Okabena Investment Services reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Okabena Investment Services sold 3,119 Elevance Health shares in Q2 2025, an estimated $1.36M.
  • Okabena Investment Services first reported a position in Elevance Health in Q4 2019 and held it in 7 quarters.
  • Okabena Investment Services's Elevance Health position peaked at $1.36M in Q1 2025.
  • 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Okabena Investment Services's 13F filing for Q2 2025, filed 13 Aug 2025.